News

The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
By Lori Solomon HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
While it is not the most common allergy in the country, almost 2 million Americans have an allergy to soy, according to Food ...
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...